Irving-based Fluor Corporation announced Thursday that it has been awarded over $1 billion in two different life sciences contracts recently.
The larger project of the two involves mobilizing resources in the central U.S. “for the first phase of a new life sciences production facility valued at $574 million,” Fluor stated.
The other contract, for $487 million, involves a biotech expansion project in Denmark.
Richard Meserole, president of Fluor’s advanced technologies and life sciences business, said his company is excited to see “the significant investments being made globally in the production of cutting-edge technologies and pharmaceuticals that will improve the lives of billions of people.”
“Delivering these projects will help to increase the speed-to-market and meet the overwhelming demand for new medicines,” Meserole added in a statement.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.